Decongestant Safety and Efficacy

Comparison of Blood Pressure Effects

The American Academy of Allergy, Asthma, and Immunology recommends that for patients concerned about blood pressure effects, topical nasal decongestants like Afrin (oxymetazoline) are generally safer than oral decongestants like Sudafed (pseudoephedrine), as long as they are used for short-term relief only 1, 2
Oral pseudoephedrine causes systemic effects as an α-adrenergic agonist that acts as a vasoconstrictor, increasing systolic blood pressure by 0.99 mmHg (95% CI, 0.08-1.90) and heart rate by 2.83 beats/min (95% CI, 2.0-3.6) 1
Topical nasal decongestants like oxymetazoline primarily cause local vasoconstriction in the nasal mucosa, with minimal systemic absorption compared to oral decongestants 1, 2

The American Academy of Allergy, Asthma, and Immunology suggests that Afrin (oxymetazoline) is best for short-term relief of nasal congestion (3 days or less) and is appropriate for acute bacterial or viral infections, exacerbations of allergic rhinitis, and Eustachian tube dysfunction 3, 4, 1
Patients with controlled hypertension should be monitored when taking pseudoephedrine, and Afrin is preferred for short-term use (≤3 days) 2, 3
Pseudoephedrine should be used with caution in patients with hypertension, arrhythmias, angina pectoris, coronary artery disease, cerebrovascular disease, hyperthyroidism, and glaucoma, due to potential increased risk of adverse cardiovascular events 1, 4, 5

For normotensive patients, both medications can be used with appropriate precautions, but Afrin is preferable for short-term use (≤3 days) 1
For patients with uncontrolled hypertension, it is recommended to avoid both medications if possible, and if decongestant therapy is necessary, short-term Afrin (≤3 days) under medical supervision is preferable 4
Elderly patients and those with cardiovascular disease should use extra caution with both medications, and Afrin for very short-term use (1-2 days) is generally safer 6

Combining sympathomimetic drugs like pseudoephedrine with topical nasal decongestants like oxymetazoline can potentially lead to serious adverse reactions, including hypertensive crisis, due to their combined vasoconstrictive effects 7

Pseudoephedrine should be used with particular caution in patients with hypertension, arrhythmias, coronary artery disease, cerebrovascular disease, hyperthyroidism, or glaucoma 7, 8
The American College of Cardiology recommends using pseudoephedrine for the shortest duration possible, especially in patients with cardiovascular concerns 8

The risk of adverse events increases when multiple decongestants are used concurrently, including the risk of hypertensive crisis and stroke 7